nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Testosterone Propionate—COMT—Parkinson's disease	0.0346	0.588	CrCbGaD
Finasteride—Testosterone—MAOA—Parkinson's disease	0.0113	0.192	CrCbGaD
Finasteride—SRD5A1—Metabolism—GCH1—Parkinson's disease	0.00661	0.00703	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GCH1—Parkinson's disease	0.00661	0.00703	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TALDO1—Parkinson's disease	0.00652	0.00692	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—OMD—Parkinson's disease	0.00652	0.00692	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00634	0.00673	CbGpPWpGaD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00626	0.00665	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NDUFB11—Parkinson's disease	0.00618	0.00656	CbGpPWpGaD
Finasteride—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00613	0.00652	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00597	0.00634	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00597	0.00634	CbGpPWpGaD
Finasteride—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00591	0.00628	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GCH1—Parkinson's disease	0.00589	0.00626	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GBA—Parkinson's disease	0.00589	0.00626	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GBA—Parkinson's disease	0.00589	0.00626	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—DBH—Parkinson's disease	0.00589	0.00626	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—FBP1—Parkinson's disease	0.00589	0.00626	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—DBH—Parkinson's disease	0.00589	0.00626	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—FBP1—Parkinson's disease	0.00589	0.00626	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00562	0.00597	CbGpPWpGaD
Finasteride—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00561	0.00596	CbGpPWpGaD
Finasteride—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00552	0.00586	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00546	0.00581	CbGpPWpGaD
Finasteride—Progesterone—CYP2D6—Parkinson's disease	0.00542	0.0922	CrCbGaD
Finasteride—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00539	0.00573	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00532	0.00565	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—DBH—Parkinson's disease	0.00525	0.00558	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—FBP1—Parkinson's disease	0.00525	0.00558	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GBA—Parkinson's disease	0.00525	0.00558	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00514	0.00546	CbGpPWpGaD
Finasteride—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00513	0.00545	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00501	0.00532	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00494	0.00525	CbGpPWpGaD
Finasteride—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00493	0.00524	CbGpPWpGaD
Finasteride—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00462	0.00491	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.0046	0.00489	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00458	0.00487	CbGpPWpGaD
Finasteride—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00456	0.00485	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00452	0.0048	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTA4—Parkinson's disease	0.00451	0.00479	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00444	0.00472	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—DDC—Parkinson's disease	0.00433	0.0046	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—DDC—Parkinson's disease	0.00433	0.0046	CbGpPWpGaD
Finasteride—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00423	0.00449	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00423	0.00449	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTA4—Parkinson's disease	0.00409	0.00434	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTA4—Parkinson's disease	0.00409	0.00434	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00406	0.00432	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00403	0.00429	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00403	0.00429	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—MAOB—Parkinson's disease	0.00402	0.00427	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00388	0.00412	CbGpPWpGaD
Finasteride—Progesterone—ABCB1—Parkinson's disease	0.00387	0.0658	CrCbGaD
Finasteride—AKR1D1—Metabolism—DDC—Parkinson's disease	0.00386	0.0041	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00371	0.00395	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PLA2G6—Parkinson's disease	0.00368	0.00391	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PLA2G6—Parkinson's disease	0.00368	0.00391	CbGpPWpGaD
Finasteride—Testosterone—ABCB1—Parkinson's disease	0.00366	0.0622	CrCbGaD
Finasteride—SRD5A1—Metabolism—MAOB—Parkinson's disease	0.00364	0.00387	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—MAOB—Parkinson's disease	0.00364	0.00387	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTA4—Parkinson's disease	0.00364	0.00387	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.0036	0.00382	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00347	0.00368	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00347	0.00368	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00336	0.00357	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PLA2G6—Parkinson's disease	0.00328	0.00348	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTA4—Parkinson's disease	0.00326	0.00346	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—MAOB—Parkinson's disease	0.00325	0.00345	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00321	0.00341	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00309	0.00328	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00306	0.00325	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP2D6—Parkinson's disease	0.00298	0.00317	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00294	0.00313	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—MAOB—Parkinson's disease	0.0029	0.00308	CbGpPWpGaD
Finasteride—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00275	0.00292	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP2E1—Parkinson's disease	0.00273	0.0029	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP2D6—Parkinson's disease	0.00271	0.00288	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP2D6—Parkinson's disease	0.00271	0.00288	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00269	0.00286	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CTGF—Parkinson's disease	0.00266	0.00282	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CTGF—Parkinson's disease	0.00266	0.00282	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00263	0.0028	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00262	0.00278	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00254	0.0027	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP2E1—Parkinson's disease	0.00248	0.00263	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP2E1—Parkinson's disease	0.00248	0.00263	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—NQO1—Parkinson's disease	0.00245	0.0026	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—NQO1—Parkinson's disease	0.00245	0.0026	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—TH—Parkinson's disease	0.00241	0.00256	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—TH—Parkinson's disease	0.00241	0.00256	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP2D6—Parkinson's disease	0.00241	0.00256	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CTGF—Parkinson's disease	0.00237	0.00252	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00233	0.00247	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYCS—Parkinson's disease	0.00232	0.00246	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYCS—Parkinson's disease	0.00232	0.00246	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0023	0.00244	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—COMT—Parkinson's disease	0.00226	0.0024	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTP1—Parkinson's disease	0.00225	0.00239	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—MAOA—Parkinson's disease	0.00225	0.00239	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—COMT—Parkinson's disease	0.00223	0.00237	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00222	0.00236	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP2E1—Parkinson's disease	0.00221	0.00234	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NQO1—Parkinson's disease	0.00218	0.00232	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP2D6—Parkinson's disease	0.00216	0.00229	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TH—Parkinson's disease	0.00215	0.00228	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00213	0.00226	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00213	0.00226	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.0021	0.00223	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GSTM1—Parkinson's disease	0.00207	0.0022	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYCS—Parkinson's disease	0.00206	0.00219	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—COMT—Parkinson's disease	0.00205	0.00218	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—COMT—Parkinson's disease	0.00205	0.00218	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTP1—Parkinson's disease	0.00204	0.00217	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTP1—Parkinson's disease	0.00204	0.00217	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00204	0.00217	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—MAOA—Parkinson's disease	0.00204	0.00216	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—MAOA—Parkinson's disease	0.00204	0.00216	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—HMOX1—Parkinson's disease	0.00201	0.00214	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—HMOX1—Parkinson's disease	0.00201	0.00214	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP2E1—Parkinson's disease	0.00197	0.0021	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00195	0.00207	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ABCB1—Parkinson's disease	0.00193	0.00205	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ABCB1—Parkinson's disease	0.00193	0.00205	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00189	0.00201	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GSTM1—Parkinson's disease	0.00188	0.00199	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GSTM1—Parkinson's disease	0.00188	0.00199	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—COMT—Parkinson's disease	0.00183	0.00194	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTP1—Parkinson's disease	0.00182	0.00193	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—MAOA—Parkinson's disease	0.00182	0.00193	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GPX1—Parkinson's disease	0.0018	0.00191	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GPX1—Parkinson's disease	0.0018	0.00191	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—HMOX1—Parkinson's disease	0.00179	0.00191	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00173	0.00183	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ABCB1—Parkinson's disease	0.00172	0.00183	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GSTM1—Parkinson's disease	0.00167	0.00178	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—MTHFR—Parkinson's disease	0.00166	0.00176	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—MTHFR—Parkinson's disease	0.00166	0.00176	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—COMT—Parkinson's disease	0.00163	0.00174	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTP1—Parkinson's disease	0.00163	0.00173	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.00162	0.00172	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.00161	0.00171	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.0016	0.00171	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GPX1—Parkinson's disease	0.0016	0.0017	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—APOE—Parkinson's disease	0.00154	0.00164	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—APOE—Parkinson's disease	0.00154	0.00164	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00151	0.00161	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.0015	0.00159	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00149	0.00159	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—MTHFR—Parkinson's disease	0.00148	0.00157	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00147	0.00157	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ND3—Parkinson's disease	0.00147	0.00156	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MCCC1—Parkinson's disease	0.00147	0.00156	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00142	0.00151	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TALDO1—Parkinson's disease	0.00138	0.00147	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—OMD—Parkinson's disease	0.00138	0.00147	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—APOE—Parkinson's disease	0.00138	0.00146	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00135	0.00143	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—INS—Parkinson's disease	0.00132	0.0014	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—INS—Parkinson's disease	0.00132	0.0014	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NDUFB11—Parkinson's disease	0.00131	0.00139	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GCH1—Parkinson's disease	0.00125	0.00133	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—INS—Parkinson's disease	0.00118	0.00125	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GBA—Parkinson's disease	0.00111	0.00118	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—DBH—Parkinson's disease	0.00111	0.00118	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—FBP1—Parkinson's disease	0.00111	0.00118	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ND3—Parkinson's disease	0.00106	0.00113	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.00106	0.00113	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.001	0.00107	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000997	0.00106	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000997	0.00106	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000989	0.00105	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.000945	0.001	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000917	0.000975	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000905	0.000961	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GCH1—Parkinson's disease	0.000902	0.000958	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—DDC—Parkinson's disease	0.000816	0.000867	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GBA—Parkinson's disease	0.000804	0.000854	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—FBP1—Parkinson's disease	0.000804	0.000854	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—DBH—Parkinson's disease	0.000804	0.000854	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTA4—Parkinson's disease	0.00077	0.000819	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.00076	0.000808	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000757	0.000804	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000755	0.000802	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.00075	0.000797	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000746	0.000793	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000695	0.000739	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	0.000694	0.000737	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MAOB—Parkinson's disease	0.000687	0.00073	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000686	0.000728	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—DDC—Parkinson's disease	0.00059	0.000627	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTA4—Parkinson's disease	0.000557	0.000592	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	0.00051	0.000542	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	0.000501	0.000533	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CTGF—Parkinson's disease	0.000501	0.000532	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MAOB—Parkinson's disease	0.000496	0.000527	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000493	0.000524	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000493	0.000524	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	0.000467	0.000496	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000463	0.000492	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000463	0.000492	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NQO1—Parkinson's disease	0.000462	0.00049	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TH—Parkinson's disease	0.000455	0.000483	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000439	0.000467	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYCS—Parkinson's disease	0.000437	0.000464	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000419	0.000445	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—COMT—Parkinson's disease	0.000387	0.000411	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTP1—Parkinson's disease	0.000385	0.000409	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MAOA—Parkinson's disease	0.000384	0.000408	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HMOX1—Parkinson's disease	0.00038	0.000403	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000374	0.000397	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000374	0.000397	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000374	0.000397	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	0.000369	0.000392	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCB1—Parkinson's disease	0.000364	0.000387	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CTGF—Parkinson's disease	0.000362	0.000385	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTM1—Parkinson's disease	0.000354	0.000376	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GPX1—Parkinson's disease	0.000339	0.00036	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	0.000337	0.000359	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NQO1—Parkinson's disease	0.000334	0.000355	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TH—Parkinson's disease	0.000329	0.000349	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYCS—Parkinson's disease	0.000316	0.000335	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTHFR—Parkinson's disease	0.000313	0.000332	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APOE—Parkinson's disease	0.000291	0.000309	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—COMT—Parkinson's disease	0.00028	0.000297	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTP1—Parkinson's disease	0.000278	0.000296	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MAOA—Parkinson's disease	0.000278	0.000295	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HMOX1—Parkinson's disease	0.000274	0.000292	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000274	0.000291	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCB1—Parkinson's disease	0.000263	0.00028	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000259	0.000275	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTM1—Parkinson's disease	0.000256	0.000272	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—INS—Parkinson's disease	0.000249	0.000264	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPX1—Parkinson's disease	0.000245	0.00026	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000233	0.000248	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000231	0.000245	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTHFR—Parkinson's disease	0.000226	0.00024	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APOE—Parkinson's disease	0.00021	0.000224	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—INS—Parkinson's disease	0.00018	0.000191	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000172	0.000182	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000168	0.000179	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000157	0.000167	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000155	0.000165	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TH—Parkinson's disease	0.000153	0.000162	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000147	0.000156	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—COMT—Parkinson's disease	0.00013	0.000138	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.000129	0.000137	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000129	0.000137	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.000128	0.000136	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.000122	0.00013	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.000119	0.000126	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPX1—Parkinson's disease	0.000114	0.000121	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTHFR—Parkinson's disease	0.000105	0.000112	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APOE—Parkinson's disease	9.78e-05	0.000104	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—INS—Parkinson's disease	8.36e-05	8.88e-05	CbGpPWpGaD
